Table 3 The concentrations of urinary speciated inorganic arsenic metabolites (in µg/L) by work group

Clean

AM

1.87

0.95

3.60

48.70

2.82

6.42

55.12

(N = 8)

GM

1.73

0.76

3.45

43.65

2.58

6.11

51.32

GSD

1.54

1.99

1.38

1.72

1.57

1.42

1.52

Med

2.03

0.68

3.40

48.84

2.61

6.71

54.55

Min

0.83

0.34

1.94

14.07

1.17

3.11

23.60

Max

2.63

2.52

5.37

88.30

5.14

9.53

93.15

Ion implantation

AM

1.88

0.48

3.26

27.23

2.36

5.62

32.85

(N = 13)

GM

1.74

0.39

3.08

23.17

2.23

5.34

28.92

GSD

1.51

2.11

1.42

1.76

1.43

1.40

1.66

Med

1.86

0.50

2.96

19.94

2.30

5.51

25.86

Min

0.76

0.10

1.84

12.28

1.21

3.25

16.35

Max

4.09

0.94

5.37

69.39

4.53

9.89

74.07

Office

AM

1.26

0.27

2.47

30.47

1.53

4.00

34.47

(N = 14)

GM

0.95

0.18

2.10

23.43

1.17

3.37

27.57

GSD

1.86

2.36

1.83

2.22

1.82

1.74

2.08

Med

0.74

0.10

2.27

28.35

1.07

3.27

31.70

Min

0.55

0.10

0.62

6.30

0.65

1.33

8.22

Max

6.51

1.28

6.50

60.18

7.80

14.30

65.15

All

AM

1.63

0.50

3.02

33.43

2.13

5.15

38.59

(N = 35)

GM

1.36

0.33

2.71

26.90

1.78

4.58

32.35

GSD

1.79

2.60

1.65

2.01

1.80

1.65

1.88

Med

1.14

0.41

2.88

29.62

1.70

4.67

36.93

Min

0.55

0.10

0.62

6.30

0.65

1.33

8.22

Max

6.51

2.52

6.50

88.30

7.80

14.30

93.15

P-value

<0.05

<0.05

<0.05

0.08

<0.05

<0.05

0.06